Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
MedImmune and Immunocore enter immunotherapy agreement to develop novel cancer therapies
-
AstraZeneca and Bristol-Myers Squibb announce US FDA approval of FARXIGA™ (dapagliflozin)
-
AstraZeneca and Shionogi settle arbitration and extend licence agreement for CRESTOR®
-
AstraZeneca to acquire Bristol-Myers Squibb share of global diabetes alliance assets
-
AstraZeneca statement in response to reports of a launch of esomeprazole strontium product in the US
-
AstraZeneca announces top-line results from phase III monotherapy study of lesinurad in gout patients
-
FDA Advisory Committee votes on investigational medicine metreleptin
-
FDA Advisory Committee recommends the investigational SGLT2 inhibitor dapagliflozin for treatment of type 2 diabetes in adults
-
AstraZeneca donates Brixham Environmental Laboratory to Plymouth University
-
European Commission approves Fluenz Tetra for the prevention of seasonal influenza in children
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
